文献速递分子诊断质量管理与危急值临床微生物

理解、验证与实施用于检测SARS-CoV-2 RNA的紧急使用授权分子诊断方法

Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA.
PubMed 文献 · J Clin Microbiol · 2020-07-23

SARS-CoV-2大流行对快速诊断测试的开发与实施带来新挑战,急性COVID-19诊断关键依赖临床标本中SARS-CoV-2 RNA检测。多数临床微生物实验室依赖商业SARS-CoV-2分子检测,这些检测获FDA紧急使用授权(EUA)而非正式批准。本文提供对EUA检测方法进行验证的指导。

要点

  • 多数临床微生物实验室依赖商业EUA SARS-CoV-2分子检测。
  • 实验室对EUA分类不熟悉,检测验证可能困难。
  • 供应链问题要求实验室实施多种商业EUA检测。

核心结论

  • 本文为临床标本中SARS-CoV-2核酸EUA检测的验证提供指导。

研究设计与样本

  • 本文为指导性文章,未报告系统检索或样本量。

主要发现

  • 多数临床微生物实验室依赖商业SARS-CoV-2分子检测,这些检测获EUA而非FDA批准或许可。
  • 供应链问题严重影响了检测试剂的可用性,要求实验室实施多种商业EUA检测。

临床怎么用

  • 临床微生物实验室可参考本文指导对EUA SARS-CoV-2分子检测进行验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has brought a new wave of challenges to health care, particularly in the area of rapid diagnostic test development and implementation. The diagnosis of acute coronavirus disease 2019 (COVID-19) is critically dependent on the detection of SARS-CoV-2 RNA from clinical specimens (e.g., nasopharyngeal swabs). While laboratory-developed testing for SARS-CoV-2 is an essential component of diagnostic testing for this virus, the majority of clinical microbiology laboratories are dependent on commercially available SARS-CoV-2 molecular assays. In contrast to assays approved or cleared by the U.S. Food and Drug Administration (FDA) for in vitro diagnostic use, assays for the detection of SARS-CoV-2 nucleic acids have emergency use authorization (EUA) from the FDA. Outside of highly specialized academic and commercial laboratory settings, clinical microbiology laboratories are likely unfamiliar with the EUA classification, and thus, assay verification can be daunting. Further compounding anxiety for laboratories are major issues with the supply chain that are dramatically affecting the availability of test reagents and requiring laboratories to implement multiple commercial EUA tests. Here, we describe guidance for the verification of assays with EUA for the detection of SARS-CoV-2 nucleic acid from clinical specimens.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Mitchell SL, St George K, Rhoads DD, et al. Understanding, Verifying, and Implementing Emergency Use Authorization Molecular Diagnostics for the Detection of SARS-CoV-2 RNA. J Clin Microbiol. 2020. PMID: 32381642. doi:10.1128/JCM.00796-20

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。